Velmanase alfa – December 2025

• Brand names:
  • Lamzede®
• Pharmaceutical Company:
  • CHIESI AUSTRALIA PTY LTD
• Condition/Indication: Alpha-mannosidosis
• Meeting Date: December 2025
• Public Summary Document (PSD) July 2025 - December 2025 PBAC Meetings – (PDF 1.5MB)
• Public Summary Document (PSD) July 2025 - December 2025 PBAC Meetings – (Word 664KB)

Related Public Summary Documents

• Velmanase Alpha – July 2025